Human papillomavirus seroprevalence in young Thai men. Issue 2 (4th March 2022)

• Record Type: Journal Article
• Authors: Khanijou, Patchariya; Tabprasit, Sutchana; Chuenchitra, Thippawan; Ruamsap, Nattaya; Islam, Dilara; Gonwong, Siriphan; Kana, Khunakorn; Swierczewski, Brett E.; Demons, Samandra T.; Waters, Norman C.; Bodhidatta, Ladaporn
• Is Part Of: Journal of immunoassay & immunochemistry. Volume 43:Issue 2(2022)
• Page Start: 222
• Page End: 229
• Publication Date: 2022-03-04
• Subjects: Human papillomavirus -- sexually transmitted infections -- seroprevalence -- Thailand; Immunoassay -- Periodicals; Immunochemistry -- Periodicals; Immunoassay -- periodicals; Immunochemistry -- periodicals; 571.96405
• DOI: 10.1080/15321819.2021.1985515
• Languages: English
• ISSNs: 1532-1819

Abstract

ABSTRACT: Human papillomavirus (HPV) is one of the most common sexually transmitted infections in men and women. Most HPV studies have focused on vaccination toward women to prevent consequences of developing cervical cancer. However, persistent infections can cause penile, anal, and oropharyngeal cancers in men. Therefore, recent public health recommendations toward vaccination in men have been raised. There is limited HPV prevalence data among men in many countries, including Thailand. We conducted HPV sera IgG ELISA testing on a repository sera of Thai men (average age 21 years old) entering the Royal Thai Army as recruits in 2013 (n = 1000). HPV IgG antibodies against virus-like particles of HPV- type 6, 11, 16e, and 18 were evaluated using a commercial ELISA kit. Overall, the anti-HPV IgG was 47% (95% CI: 44%-50%). HPV seroprevalence was significantly associated with residence regions with the highest prevalence in South (64%), but not associated with educational level, marital status, or type of residence. This data suggested that almost half of the Thai men in this cohort were exposed to HPV by the age of 21. Thus, HPV vaccination provided to male adolescents should be considered for disease prevention and minimizing transmission to sexual partners.